February 22, 2017: Eyegate Pharma announced yesterday that it had inked an exclusive, global licensing deal with Laval, Quebec-based Valeant. The deal caused the stock to explode, doubling its market cap.
February 22, 2017: Hours after BMS announced a $2B stock buyback plan on Tuesday, billionaire investor Carl Icahn snapped up a “large stake” of BMS stock, which sent shares soaring.
February 22, 2017: Agenus quietly filed with the U.S. SEC that it was halting its clinical trial of its cancer vaccine Prophage. On February 17, 2017, the company was notified by the Alliance for Clinical Trials in Oncology, indicated failure.
February 22, 2017: Fortune magazine collaborated with Korn Ferry Hay Group on a survey of corporate reputations. They started with about 1,500 candidates that included the 1,000 largest U.S. companies by revenue.